Development and validation of a multiparametric MRI-based radiomics signature for distinguishing between indolent and aggressive prostate cancer.
2021
Objectives:To develop and validate a noninvasive MRI-based radiomics signature for distinguishing between indolent and aggressive prostate cancer (PCa) prior to therapy.Methods:In all, 139 qualifie...
-
Correction
-
Source
-
Cite
-
Save
39
References
0
Citations
NaN
KQI